ADAPY — Adaptimmune Therapeutics PLC
—
·
Health Care ·
Biotechnology ·
CIK 1621227 ·
United Kingdom
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-04-23
No quarterly fundamentals indexed for this ticker.
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $191.70B | $355.20 | — |
| GILD | GILEAD SCIENCES, INC. | $155.93B | $125.59 | — |
| ARGX | ARGENX SE | $55.57B | $893.52 | — |
| RVMD | Revolution Medicines, Inc. | $32.71B | $153.87 | — |
| BIIB | BIOGEN INC. | $29.53B | $200.05 | — |
News headlines (Yahoo Finance, 1h cache)
Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome
2026-01-08 13:00 · Yahoo
Adaptimmune Announces Changes to Board and Executive Leadership Team
2025-11-17 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.